Curtiss-Wright Corporation

The stock's FTSE Russell reclassification into growth-focused indexes like the Russell 1000 Growth, combined with rising net profit margin assumptions (now ~16.20%) and an upward revision of fair value to ~$791, suggests the premium multiple reflects genuine earnings quality and structural growth re-rating.

At a P/E ratio of 57.89, InvestingPro analysis flags the stock as potentially overvalued at current levels, and Citigroup maintains a 'neutral' rating with a comparatively modest $793 target, implying limited upside relative to the risk embedded in the lofty valuation.

Morgan Stanley reaffirmed an 'overweight' rating and raised its price target to $860, while Robert W. Baird set a $870 target, both well above current trading levels. The consensus average of ~$817 implies approximately 9% upside, underpinned by strong Q1 2026 earnings beats on both EPS and revenue.

Stifel Nicolaus set a notably lower price target of $724 — a significant discount to peers — and Weiss Ratings downgraded the stock from 'buy (b)' to 'buy (b-)', reflecting growing caution. The wide $146 spread between the lowest and highest targets signals deep disagreement about the stock's true worth.

Curtiss-Wright's stock surged 24% in Q1 2026 and has posted a 64.74% gain over the past year, driven by robust defense and nuclear market demand. Analysts revised long-term revenue growth assumptions to ~7.59% and raised the future P/E multiple to ~46.59x, reflecting confidence in durable earnings expansion.

Short interest increased by nearly 5% in the most recent reporting period to over 810,000 shares, signaling that a growing number of market participants are positioning against the stock. A post-earnings drift signal also projected a negative outlook following the latest earnings release, raising questions about whether recent momentum is sustainable.